Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.
The goal of this study is to determine if aspirin (acetylsalicylic acid) alters emotional reactions to emotion evoking pictures as well as memory for them. Using a double-blind parallel arm study, participants will receive either placebo or a pain-relieving dose of aspirin (500mg). One hour later they will complete 30 minutes of tasks. This will include ratings of emotional pictures and memory for them. The paradigm is similar to previous experiments done in this lab using other cyclooxygenase inhibitors: ibuprofen and acetaminophen (Durso, Luttrell, & Way, 2015; Psychological Science, https://doi.org/10.1177/0956797615570366). Risk taking on the Balloon Analogue Risk Task will also be assessed. Participants will be healthy young adult males at Ohio State University.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator | Single dose of a 500mg placebo tablet. |
|
| Aspirin 500MG | Active Comparator | Single dose of a 500 mg aspirin tablet. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aspirin 500 MG | Drug | Single 500mg aspirin capsule. |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Emotional Reactivity | Changes in self-reported evaluations of valence on a 1 to 7 scale and felt reactions to emotional images on a 1-7 scale. | 1.5 hours |
| Memory | Changes in memory for emotional pictures. After rating the images, the participants will be shown them again as well as new pictures and asked to indicate whether they have seen the picture before or not. | 1.5 hours |
| Risk-Taking | We will measure the adjusted average number of pumps on the Balloon Analogue Risk Task. | 1.5 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Individual Differences | Self-reported political ideology will be examined as a moderator of the self-reported ratings of the images as well as memory for them. | 1.5 hours |
Not provided
Inclusion Criteria:
At least 18 years old and biologically male
Exclusion Criteria:
Due to the use of aspirin in this study, women will be excluded from the study due to potential negative effects it may have on pregnancy
Participants will also be excluded for the following medical reasons:
Must be biologically male to participate in study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Psychology Building | Columbus | Ohio | 43210 | United States |
Deidentified data will be made available online for responses to the tasks.
The dataset and annotation will be made available by 7/1/2023
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Apr 28, 2020 | Apr 28, 2020 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D012309 | Risk-Taking |
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D001241 | Aspirin |
| ID | Term |
|---|---|
| D012459 | Salicylates |
| D062385 | Hydroxybenzoates |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
Not provided
Not provided
Note. 135 of an originally intended 200 participants had been enrolled at the time of cessation of research activities due to COVID-19 research closures. Therefore, the intended sample was increased to 270 to allow comparison between pre-COVID and post-COVID participants.
Not provided
Not provided
Not provided
| Placebo | Drug | Single 500mg placebo capsule. |
|
| D006841 |
| Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |